Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
28/08/2025
Nvidia: Revenue from H20 products decreased by approximately $4 billion.
Latest
2 m ago
Japanese two-year government bond auction faced the weakest demand ratio since 2009.
3 m ago
Recently, the National Key Laboratory of Sensor Technology of the Aerospace Information Innovation Research Institute of the Chinese Academy of Sciences, in collaboration with the Department of Neurosurgery at the First Affiliated Hospital of Harbin Medical University, successfully completed a clinical trial on "Precise Localization of Brain Deep Tumor Borders Based on Implantable Microelectrode Arrays." This marks the first clinical trial worldwide in which brain-machine interface technology has been applied to precisely locate the boundaries of deep brain tumors during surgery, indicating a significant breakthrough in China's independently developed implantable clinical brain-machine interface technology. This technology provides real-time, high-precision "lesion navigation" for neurosurgery, with the potential to maximize the removal of tumors while protecting healthy brain tissue to the greatest extent possible. It also has important clinical value for promoting the preservation of postoperative neurological functions and quality of life for patients. (CCTV News)
3 m ago
Our country successfully completed clinical trials of precise positioning of brain deep tumor boundaries using self-developed brain-machine interfaces.
3 m ago
China holds commemorative events for the 80th anniversary of the victory in the War of Resistance Against Japan to put pressure on Japan? China responds.
4 m ago
Market news: Chery Automobile plans to conduct a 1.5 billion USD IPO in Hong Kong as early as next month.
See all latest
